Oracle to Buy Sun Microsystems: What Impact on Pharma?

April 20, 2009

After IBM announced interest then pulled back, today brought news that Oracle plans to buy Sun Microsystems for over $7 billion (click here for Bloomberg report) brings interesting questions on what new enabling technologies might soon available for drug R&D and manufacturing. A recent article in Computer Weekly examined IT's evolution in life sciences, from ancillary to critical tool.


About the Author

pharmamanufacturing | pharmamanufacturing